Pharmacoepidemiology, as an interdisciplinary domain amalgamating pharmacology and epidemiology, is dedicated to scrutinizing the real-world ramifications of pharmaceuticals within populations. Employing observational research methodologies and scrutinizing extensive datasets, pharmacoepidemiologists discern intricate patterns concerning drug employment, adverse effects, and therapeutic consequences. A pivotal objective is the provision of evidence-based insights tailored for healthcare practitioners, policymakers, and the pharmaceutical sector. This, in turn, shapes decisions regarding drug prescription practices, regulatory measures, and public health strategies. Pharmacoepidemiological inquiries incorporate diverse study designs, encompassing cohort studies and case-control analyses, to meticulously explore outcomes related to drug usage.
The field continually evolves to surmount challenges inherent in addressing confounding variables and biases during the phases of data collection, analysis, and interpretation. The accrued insights play a pivotal role in the continual refinement of clinical guidelines and the vigilance inherent in drug safety monitoring protocols.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil